Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group
about
Comparison of first-line chemotherapy based on irinotecan or other drugs to treat non-small cell lung cancer in stage IIIB/IV: a systematic review and meta-analysisIrinotecan in patients with relapsed or cisplatin-refractory germ cell cancer: a phase II study of the German Testicular Cancer Study GroupPhase II study of cisplatin, ifosfamide, and irinotecan with rhG-CSF support in patients with stage IIIb and IV non-small-cell lung cancerPhase I/II study of docetaxel and cisplatin with concurrent thoracic radiation therapy for locally advanced non-small-cell lung cancer.Incorporating Erlotinib or Irinotecan Plus Cisplatin into Chemoradiotherapy for Stage III Non-small Cell Lung Cancer According to EGFR Mutation Status.
P2860
Fractionated administration of irinotecan and cisplatin for treatment of non-small-cell lung cancer: a phase II study of Okayama Lung Cancer Study Group
description
2001 nî lūn-bûn
@nan
2001 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Fractionated administration of ...... kayama Lung Cancer Study Group
@ast
Fractionated administration of ...... kayama Lung Cancer Study Group
@en
Fractionated administration of ...... kayama Lung Cancer Study Group
@nl
type
label
Fractionated administration of ...... kayama Lung Cancer Study Group
@ast
Fractionated administration of ...... kayama Lung Cancer Study Group
@en
Fractionated administration of ...... kayama Lung Cancer Study Group
@nl
prefLabel
Fractionated administration of ...... kayama Lung Cancer Study Group
@ast
Fractionated administration of ...... kayama Lung Cancer Study Group
@en
Fractionated administration of ...... kayama Lung Cancer Study Group
@nl
P2093
P2860
P356
P1476
Fractionated administration of ...... kayama Lung Cancer Study Group
@en
P2093
M Tanimoto
N Takigawa
P2860
P2888
P356
10.1054/BJOC.2001.1861
P407
P577
2001-07-06T00:00:00Z
P5875
P6179
1013544452